Enhancing the Secondary Prevention of Coronary Artery Disease
Coronary Disease, Ischemic Heart Disease
About this trial
This is an interventional prevention trial for Coronary Disease focused on measuring Coronary disease, quality improvement, knowledge translation
Eligibility Criteria
Inclusion Criteria: Alberta residents who undergo a cardiac catheterization and are diagnosed with coronary artery disease (> or equal to 50% stenosis in at least one vessel). Exclusion Criteria: no fasting lipid panel within the previous 6 weeks on a statin at maximal dose on a statin/lipid lowering drug and LDL-C is 2.5 mmol/L or less (prior to Sept 2006) and LDL-C is 2.0 mmol/L or less (after Sept 2006) not on a statin and LDL-C is 1.8 mmol/L or less acute myocardial infarction or cardiogenic shock require emergency bypass surgery following catheterization contraindication to statins (e.g. cirrhosis, inflammatory muscle disease)
Sites / Locations
- University of Alberta Hospital; Royal Alexandra Hospital, Foothills Medical Centre (Calgary)